Merino-Galán, L., Zamarbide, M., Belloso-Iguerategui, A., Alonso-Moreno, M. C., Gago, B., Reinares-Sebastián, A., Blesa, J., Dumitriu, D., Quiroga-Varela, A., & Rodríguez-Oroz, M. C. (2025). Resilience of striatal synaptic plasticity over early structural adaptations in premotor parkinsonism. Npj Parkinson’s Disease, 11(1). https://doi.org/10.1038/s41531-025-00994-1

Johansson, E., Freuchet, A., Williams, G. P., Michealis, T., Frazier, A., Litvan, I., Goldman, J. G., Alcalay, R. N., Standaert, D. G., Amara, A. W., Stover, N., Fon, E. A., Postuma, R. B., Sidney, J., Sulzer, D., Lindestam Arlehamn, C. S., & Sette, A. (2025). T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson’s disease. Npj Parkinson’s Disease, 11(1). https://doi.org/10.1038/s41531-025-01001-3

Freuchet, A., Johansson, E., Frazier, A., Litvan, I., Goldman, J. G., Alcalay, R. N., Sulzer, D., Lindestam Arlehamn, C. S., & Sette, A. (2025). Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to α-synuclein. Npj Parkinson’s Disease, 11(1). https://doi.org/10.1038/s41531-025-00981-6

Parlar, S. C., Senkevich, K., Yu, E., Ruskey, J. A., Ahmad, J., Asayesh, F., Spiegelman, D., Waters, C., Monchi, O., Dauvilliers, Y., Dupré, N., Greenbaum, L., Hassin-Baer, S., Miliukhina, I., Timofeeva, A., Emelyanov, A., Pchelina, S., Alcalay, R. N., Fon, E. A., … Gan-Or, Z. (2025). LRRK2 rare-variant per-domain genetic burden in Parkinson’s Disease: association confined to the kinase domain. Npj Parkinson’s Disease, 11(1). https://doi.org/10.1038/s41531-025-00934-z

Barbuti, P. A., Guardia-Laguarta, C., Yun, T., Chatila, Z. K., Flowers, X., Wong, C., Santos, B. F. R., Larsen, S. B., Lotti, J. S., Hattori, N., Bradshaw, E., Dettmer, U., Fanning, S., Menon, V., Reddy, H., Teich, A. F., Krüger, R., Area-Gomez, E., & Przedborski, S. (2025). The role of alpha-synuclein in synucleinopathy: Impact on lipid regulation at mitochondria–ER membranes. Npj Parkinson’s Disease, 11(1). https://doi.org/10.1038/s41531-025-00960-x

Ren, W.-H., Chen, B., He, J.-Q., Qi, Y.-M., Yan, Y.-Y., Jin, S.-X., & Chang, Y. (2025). Patterns of cerebellar cortex hypermetabolism on motor and cognitive functions in PD. Npj Parkinson’s Disease, 11(1). https://doi.org/10.1038/s41531-025-00931-2

Dam, T., Pagano, G., Brumm, M. C., Gochanour, C., Poston, K. L., Weintraub, D., Chahine, L. M., Coffey, C., Tanner, C. M., Kopil, C. M., Xiao, Y., Chowdhury, S., Concha-Marambio, L., DiBiaso, P., Foroud, T., Frasier, M., Jennings, D., Kieburtz, K., Merchant, K., … Wubuli, D. (2024). Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts. Npj Parkinson’s Disease, 10(1). https://doi.org/10.1038/s41531-024-00789-w

Oas, H., Cook, L., Schwantes-An, T.-H., Walsh, L. E., Wills, A.-M., Mata, I. F., Nance, M. A., Beck, J. C., Naito, A., Marder, K., Alcalay, R. N., & Verbrugge, J. (2024). Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation. Npj Parkinson’s Disease, 10(1). https://doi.org/10.1038/s41531-024-00805-z

Senkevich, K., Parlar, S. C., Chantereault, C., Yu, E., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., Waters, C., Monchi, O., Dauvilliers, Y., Dupré, N., Miliukhina, I., Timofeeva, A., Emelyanov, A., Pchelina, S., Greenbaum, L., Hassin-Baer, S., Alcalay, R. N., & Gan-Or, Z. (2024). Are rare heterozygous SYNJ1 variants associated with Parkinson’s disease? Npj Parkinson’s Disease, 10(1). https://doi.org/10.1038/s41531-024-00809-9

Wang, V. A., Delaney, S., Flynn, L. E., Racette, B. A., Miller, G. W., Braun, D., Zanobetti, A., & Mork, D. (2024). The effect of air pollution on hospitalizations with Parkinson’s disease among medicare beneficiaries nationwide. Npj Parkinson’s Disease, 10(1). https://doi.org/10.1038/s41531-024-00815-x

Gala, A. S., Wilkins, K. B., Petrucci, M. N., Kehnemouyi, Y. M., Velisar, A., Trager, M. H., & Bronte-Stewart, H. M. (2024). The digital signature of emergent tremor in Parkinson’s disease. Npj Parkinson’s Disease, 10(1). https://doi.org/10.1038/s41531-024-00754-7

Weber, S., Menees, K. B., Park, J., Agin-Liebes, J., Lin, C.-C., Alcalay, R. N., & Lee, J.-K. (2024). Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients. Npj Parkinson’s Disease, 10(1). https://doi.org/10.1038/s41531-024-00652-y

Ramalingam, N., Jin, S.-X., Moors, T. E., Fonseca-Ornelas, L., Shimanaka, K., Lei, S., Cam, H. P., Watson, A. H., Brontesi, L., Ding, L., Hacibaloglu, D. Y., Jiang, H., Choi, S. J., Kanter, E., Liu, L., Bartels, T., Nuber, S., Sulzer, D., Mosharov, E. V., … Dettmer, U. (2023). Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity. Npj Parkinson’s Disease, 9(1). https://doi.org/10.1038/s41531-023-00444-w

Avisar, H., Guardia-Laguarta, C., Surface, M., Papagiannakis, N., Maniati, M., Antonellou, R., Papadimitriou, D., Koros, C., Athanassiadou, A., Przedborski, S., Lerner, B., Stefanis, L., Area-Gomez, E., & Alcalay, R. N. (2022). Lipid level alteration in human and cellular models of alpha synuclein mutations. Npj Parkinson’s Disease, 8(1). https://doi.org/10.1038/s41531-022-00313-y

Kedariti, M., Frattini, E., Baden, P., Cogo, S., Civiero, L., Ziviani, E., Zilio, G., Bertoli, F., Aureli, M., Kaganovich, A., Cookson, M. R., Stefanis, L., Surface, M., Deleidi, M., Di Fonzo, A., Alcalay, R. N., Rideout, H., Greggio, E., & Plotegher, N. (2022). LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease. Npj Parkinson’s Disease, 8(1). https://doi.org/10.1038/s41531-022-00354-3

Dhanwani, R., Lima-Junior, J. R., Sethi, A., Pham, J., Williams, G., Frazier, A., Xu, Y., Amara, A. W., Standaert, D. G., Goldman, J. G., Litvan, I., Alcalay, R. N., Peters, B., Sulzer, D., Arlehamn, C. S. L., & Sette, A. (2022). Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures. Npj Parkinson’s Disease, 8(1). https://doi.org/10.1038/s41531-022-00282-2

Cook, L., Schulze, J., Uhlmann, W. R., Verbrugge, J., Marder, K., Lee, A. J., Wang, Y., Alcalay, R. N., Nance, M., & Beck, J. C. (2022). Tools for communicating risk for Parkinson’s disease. Npj Parkinson’s Disease, 8(1). https://doi.org/10.1038/s41531-022-00432-6

Simuni, T., Merchant, K., Brumm, M. C., Cho, H., Caspell-Garcia, C., Coffey, C. S., Chahine, L. M., Alcalay, R. N., Nudelman, K., Foroud, T., Mollenhauer, B., Siderowf, A., Tanner, C., Iwaki, H., Sherer, T., Marek, K., Siderowf, A., … Tauscher, J. (2022). Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort. Npj Parkinson’s Disease, 8(1). https://doi.org/10.1038/s41531-022-00404-w

Petropoulou-Vathi, L., Simitsi, A., Valkimadi, P.-E., Kedariti, M., Dimitrakopoulos, L., Koros, C., Papadimitriou, D., Papadimitriou, A., Stefanis, L., Alcalay, R. N., & Rideout, H. J. (2022). Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts. Npj Parkinson’s Disease, 8(1). https://doi.org/10.1038/s41531-022-00336-5

Chalazonitis, A., Rao, M., & Sulzer, D. (2022). Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson’s disease. Npj Parkinson’s Disease, 8(1). https://doi.org/10.1038/s41531-022-00308-9

Liu, B., Sjölander, A., Pedersen, N. L., Ludvigsson, J. F., Chen, H., Fang, F., & Wirdefeldt, K. (2021). Irritable bowel syndrome and Parkinson’s disease risk: register-based studies. Npj Parkinson’s Disease, 7(1). https://doi.org/10.1038/s41531-020-00145-8

Feeney, M. P., Xu, Y., Surface, M., Shah, H., Vanegas-Arroyave, N., Chan, A. K., Delaney, E., Przedborski, S., Beck, J. C., & Alcalay, R. N. (2021). The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study. Npj Parkinson’s Disease, 7(1). https://doi.org/10.1038/s41531-020-00153-8